Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Kooperberg

Showing results (61-70 of 530) with videos related to

Pageof 53
Sort By:
The EMBO Journal|January 27, 2006
Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promotersYi Cao, Roshan M Kumar, Bennett H Penn, et al.
Communications Medicine|August 29, 2022
Broad clinical manifestations of polygenic risk for coronary artery disease in the Women's Health InitiativeShoa L Clarke, Matthew Parham, Joanna Lankester, et al.
Stroke|April 8, 2026
Clonal Hematopoiesis and Risk of Stroke: Evidence From Over 800 000 Individuals Across 3 CohortsKun Zhao, Yash Pershad, Liying Xue, et al.
Archives of Internal Medicine|November 13, 2008
Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapyJacques E Rossouw, Mary Cushman, Philip Greenland, et al.
Genetic Epidemiology|June 28, 2024
Proteome-wide association study using cis and trans variants and applied to blood cell and lipid-related traits in the Women's Health Initiative studyBrian D Chen, Chanhwa Lee, Amanda L Tapia, et al.
Journal of the American Geriatrics Society|November 27, 2012
Statins, angiotensin-converting enzyme inhibitors, and physical performance in older womenShelly L Gray, Aaron K Aragaki, Michael J LaMonte, et al.
Frontiers in Cardiovascular Medicine|March 10, 2023
Pregnancy loss and risk of incident CVD within 5 years: Findings from the Women's Health InitiativeCatherine E Wright, Daniel A Enquobahrie, Sarah Prager, et al.
Bone|June 6, 2013
OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational StudyAndrea Z LaCroix, Rebecca D Jackson, Aaron Aragaki, et al.
Journal of the American Geriatrics Society|May 31, 2017
Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health InitiativeRebecca L Drieling, Andrea Z LaCroix, Shirley A A Beresford, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 26, 2010
Estrogen receptor polymorphisms and the vascular effects of hormone therapyJacques Rossouw, Paul Bray, Jingmin Liu, et al.
Pageof 53

Showing results (61-70 of 530) with videos related to

Sort By:
Pageof 53
The EMBO Journal|January 27, 2006
Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promotersYi Cao, Roshan M Kumar, Bennett H Penn, et al.
Communications Medicine|August 29, 2022
Broad clinical manifestations of polygenic risk for coronary artery disease in the Women's Health InitiativeShoa L Clarke, Matthew Parham, Joanna Lankester, et al.
Stroke|April 8, 2026
Clonal Hematopoiesis and Risk of Stroke: Evidence From Over 800 000 Individuals Across 3 CohortsKun Zhao, Yash Pershad, Liying Xue, et al.
Archives of Internal Medicine|November 13, 2008
Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapyJacques E Rossouw, Mary Cushman, Philip Greenland, et al.
Genetic Epidemiology|June 28, 2024
Proteome-wide association study using cis and trans variants and applied to blood cell and lipid-related traits in the Women's Health Initiative studyBrian D Chen, Chanhwa Lee, Amanda L Tapia, et al.
Journal of the American Geriatrics Society|November 27, 2012
Statins, angiotensin-converting enzyme inhibitors, and physical performance in older womenShelly L Gray, Aaron K Aragaki, Michael J LaMonte, et al.
Frontiers in Cardiovascular Medicine|March 10, 2023
Pregnancy loss and risk of incident CVD within 5 years: Findings from the Women's Health InitiativeCatherine E Wright, Daniel A Enquobahrie, Sarah Prager, et al.
Bone|June 6, 2013
OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational StudyAndrea Z LaCroix, Rebecca D Jackson, Aaron Aragaki, et al.
Journal of the American Geriatrics Society|May 31, 2017
Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health InitiativeRebecca L Drieling, Andrea Z LaCroix, Shirley A A Beresford, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 26, 2010
Estrogen receptor polymorphisms and the vascular effects of hormone therapyJacques Rossouw, Paul Bray, Jingmin Liu, et al.
Pageof 53